The Web Health outlines the side effects of Alunbrig (brigatinib), a targeted therapy for ALK‑positive metastatic non‑small cell lung cancer. Common effects include elevated liver enzymes, hyperglycemia, nausea, fatigue, headache,... Read More
The Web Health outlines the side effects of Alunbrig (brigatinib), a targeted therapy for ALK‑positive metastatic non‑small cell lung cancer. Common effects include elevated liver enzymes, hyperglycemia, nausea, fatigue, headache,... Read More